Stay updated with breaking news from Nasdaq Vtgn. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Vistagen Therapeutics, Inc. (NASDAQ:VTGN – Get Free Report) major shareholder Commodore Capital Lp purchased 775,756 shares of the firm’s stock in a transaction that occurred on Monday, August 7th. The stock was bought at an average cost of $23.15 per share, for a total transaction of $17,958,751.40. Following the purchase, the insider now owns 1,575,000 […]
Vistagen Therapeutics, Inc. (NASDAQ:VTGN – Free Report) was the recipient of a large growth in short interest in the month of June. As of June 15th, there was short interest totalling 687,500 shares, a growth of 72.2% from the May 31st total of 399,200 shares. Based on an average trading volume of 215,700 shares, the […]
Shares of VistaGen Therapeutics, Inc. (NASDAQ:VTGN – Get Rating) passed below its fifty day moving average during trading on Wednesday . The stock has a fifty day moving average of $0.18 and traded as low as $0.14. VistaGen Therapeutics shares last traded at $0.16, with a volume of 42,395,991 shares trading hands. VistaGen Therapeutics Stock […]
VistaGen Therapeutics (NASDAQ:VTGN – Get Rating) is set to announce its earnings results after the market closes on Thursday, June 23rd. Analysts expect the company to announce earnings of ($0.06) per share for the quarter. VTGN stock opened at $0.99 on Monday. The stock has a market cap of $204.46 million, a PE ratio of […]
Equities analysts expect VistaGen Therapeutics, Inc. (NASDAQ:VTGN – Get Rating) to report earnings per share of ($0.06) for the current quarter, Zacks reports. Two analysts have provided estimates for VistaGen Therapeutics’ earnings. VistaGen Therapeutics posted earnings per share of ($0.20) during the same quarter last year, which would suggest a positive year over year growth […]